Immutep
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.About IMMP
Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731).
CEOMarc Voigt
CEOMarc Voigt
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1987
Founded1987
Employees—
Employees—
IMMP Key Statistics
Market cap64.14M
Market cap64.14M
Price-Earnings ratio-1.19
Price-Earnings ratio-1.19
Dividend yield—
Dividend yield—
Average volume1.17M
Average volume1.17M
High today$0.4485
High today$0.4485
Low today$0.4256
Low today$0.4256
Open price$0.444
Open price$0.444
Volume678.49K
Volume678.49K
52 Week high$3.53
52 Week high$3.53
52 Week low$0.2928
52 Week low$0.2928
IMMP News
TipRanks 4d
Immutep Links Eftilagimod Immune Activation to Longer Survival in Late-Stage CancerUnlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...
Barchart 5d
IMMP Shareholder Alert: July 6, 2026 Lead Plaintiff Deadline in Immutep Limited Securities Class Action - Contact The Gross Law Firm - Barchart...
Analyst ratings
67%
of 6 ratingsBuy
33.3%
Hold
66.7%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.